The global Veterinary Active Pharmaceutical Ingredients Manufacturing market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The market is primarily driven by the growing demand for veterinary drugs owing to the rising prevalence of zoonotic diseases, the increasing number of veterinary pharmaceutical players, and the growing animal population, pet ownership, pet humanization & pet expenditure.
This report aims to provide a comprehensive presentation of the global market for Veterinary Active Pharmaceutical Ingredients Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Active Pharmaceutical Ingredients Manufacturing. This report contains market size and forecasts of Veterinary Active Pharmaceutical Ingredients Manufacturing in global, including the following market information:
- Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Revenue, 2018-2023, 2024-2032, ($ millions)
- Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Sales, 2018-2023, 2024-2032, (Tons)
- Global top five Veterinary Active Pharmaceutical Ingredients Manufacturing companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Antiparasitic Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Veterinary Active Pharmaceutical Ingredients Manufacturing include Alivira Animal Health Ltd., Excel Industries Ltd., Ofichem Group, Chempro Pharma Private Ltd., Menadiona, SUANFARMA, Vetpharma (Insud Pharma, S.L.U), Siflon Drugs and Qilu Pharma, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Veterinary Active Pharmaceutical Ingredients Manufacturing manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (Tons)
Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Segment Percentages, by Type, 2022 (%)
- Antiparasitic
- Anti-infectives
- NSAIDs
- Others
Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (Tons)
Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Segment Percentages, by Application, 2022 (%)
- Companion Animals
- Production/Food Animals
Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (Tons)
Global Veterinary Active Pharmaceutical Ingredients Manufacturing Market Segment Percentages, By Region and Country, 2022 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Veterinary Active Pharmaceutical Ingredients Manufacturing revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Veterinary Active Pharmaceutical Ingredients Manufacturing revenues share in global market, 2022 (%)
- Key companies Veterinary Active Pharmaceutical Ingredients Manufacturing sales in global market, 2018-2023 (Estimated), (Tons)
- Key companies Veterinary Active Pharmaceutical Ingredients Manufacturing sales share in global market, 2022 (%)
key players include:
- Alivira Animal Health Ltd.
- Excel Industries Ltd.
- Ofichem Group
- Chempro Pharma Private Ltd.
- Menadiona
- SUANFARMA
- Vetpharma (Insud Pharma, S.L.U)
- Siflon Drugs
- Qilu Pharma
- FIS - Fabbrica Italiana Sintetici S.p.A.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Veterinary Active Pharmaceutical Ingredients Manufacturing, market overview.
Chapter 2: Global Veterinary Active Pharmaceutical Ingredients Manufacturing market size in revenue and volume.
Chapter 3: Detailed analysis of Veterinary Active Pharmaceutical Ingredients Manufacturing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Veterinary Active Pharmaceutical Ingredients Manufacturing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Veterinary Active Pharmaceutical Ingredients Manufacturing capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
